Stockholders' Equity

9 Months Ended

Sep. 30, 2017

6. Stockholders’ Equity

Convertbile Preferred Stock

The Company had authorized and issued Series Seed Preferred Stock (“Series Seed”), Series A preferred stock (“Series A”), and Series B preferred stock (“Series B”). Preferred stock outstanding as of December 31, 2016 consisted of the following (in thousands, except share and per share data):

	December 31, 2016
Series	Period Issued	Price per Share		Shares Authorized		Shares Issued and Outstanding		Aggregate Liquidation Value		Carrying Value
Seed	July 2012	$	0.25		4,660,000		4,660,000	$	1,165	$	1,156
A	November 2012 to June 2013	$	1.00		4,500,000		4,500,000		4,500		4,477
B	June 2014 to October 2014	$	2.00		2,500,000		1,582,500		3,165		3,161
Total					11,660,000		10,742,500	$	8,830	$	8,794

Prior to the closing of the Company’s IPO, all shares of the then-outstanding convertible preferred stock, as shown in the table above, converted on a one-for-one basis into common stock.

Common Stock

The Company was authorized to issue 75,000,000 shares of common stock with $0.0001 par value per share as of September 30, 2017. The shares of common stock issued and outstanding were 16,365,738 excluding 330,167 legally issued shares subject to repurchase related to the early exercise of options to purchase common stock as of September 30, 2017.

The Company has reserved the following number of shares of common stock for future issuances:

	September 30,
	2017
Outstanding stock awards		1,732,001
Shares available for future issuance under the 2017 Stock Incentive Plan		3,953,649
Total common stock reserved for future issuances		5,685,650